<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1448</ReferenceId>
        <DateLastUpdated>2016-11-03-07:00</DateLastUpdated>
        <Article>
            <PubmedId>9820132</PubmedId>
            <Abstract>The surface glycoprotein G is the major neutralizing and protective antigen of bovine ephemeral fever rhabdovirus (BEFV). Twelve neutralizing MAbs against BEFV strain BB7721 were used to select 33 neutralization escape mutants. The mutants had been classified previously into three major antigenic sites (G1-G3) based on their cross-neutralization patterns. The nucleotide sequence of the entire extracellular domain of the G protein gene was determined for all mutants. Each contained a single nucleotide change leading to a single amino acid substitution. The 16 mutants assigned to the linear antigenic site G1 mapped to aa 487-503 of the 623 aa G protein. Results of antibody binding to several overlapping octapeptides covering this region mapped the sequence of two common minimal B cell epitopes recognized by the five G1 MAbs to (488)EEDE(491) and (499)NPHE(502). Site G2 mutations mapped either at aa 169 or 187. The 12 mutants representing antigenic site G3 (G3a and G3b) mapped to aa 49, 57, 218, 229 and 265, indicating that this site is likely to combine complex discontinuous epitopes. Comparison of the deduced amino acid sequence from five BEFV field isolates and BB7721 identified aa 218 to be critical for the site G3a neutralization. Alignment of the glycoproteins of rabies virus, vesicular stomatitis Indiana virus, vesicular stomatitis New Jersey virus, infectious haematopoietic necrosis virus and BEFV revealed similarities in the location of the neutralizing epitopes and extensive conservation of cysteine residues, suggesting that basic elements of the folded structure of these glycoproteins are preserved.</Abstract>
            <ArticleYear>1998</ArticleYear>
            <ArticlePages>2573-81</ArticlePages>
            <ArticleTitle>Location of neutralizing epitopes on the G protein of bovine ephemeral fever rhabdovirus.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kongsuwan</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Cybinski</LastName>
                    <ForeName>D H</ForeName>
                </Author>
                <Author>
                    <LastName>Cooper</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Walker</LastName>
                    <ForeName>P J</ForeName>
                </Author>
            </Authors>
            <Affiliations>CSIRO Tropical Agriculture, Long Pocket Laboratories, Indooroopilly, Qld, Australia.</Affiliations>
            <ArticleChemicalList>Antigens, Viral;Glycoproteins;Immunodominant Epitopes;Viral Proteins;BEFV G protein, Bovine ephemeral fever virus</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Amino Acid Substitution; Animals; Antigens, Viral(immunology ); Cattle; Ephemeral Fever Virus, Bovine(immunology ); Epitope Mapping; Genes, Viral; Glycoproteins(immunology ); Immunodominant Epitopes(genetics; immunology ); Molecular Sequence Data; Point Mutation; Sequence Alignment; Viral Proteins(immunology )</ArticleMeshHeadingsList>
            <Journal>
                <Volume>79 ( Pt 11)</Volume>
                <Title>The Journal of general virology</Title>
                <Issn>1465-2099</Issn>
                <MedlineTa>J Gen Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>G1 EEDE</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EEDE</LinearSequence>
                        <StartingPosition>488</StartingPosition>
                        <EndingPosition>491</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P32595.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10000472</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>11541</EpitopeId>
                <ReferenceStartingPosition>488</ReferenceStartingPosition>
                <ReferenceEndingPosition>491</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Authors cite previous reference (Cybinski et al., 1990, 1992) for the identification antigenic site G1 on BEFV G protein.  Antigenic sites were identified by competitive binding studies using Mabs and cross-reactivity of escape mutants.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>22645</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10000472</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Monoclonal antibodies specific to the G protein were raised by injection of mice with BEFV (BB7721).</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Overlapping octapeptides were synthesized based on Pepscan analysis of G1 antigenic site (aa487-503) and used in ELISA to determine binding of BEFV neutralizing mAbs.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>9C5, 17B1 and 13C6</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>aa487-494</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YEEDEKFK</LinearSequence>
                                        <StartingPosition>487</StartingPosition>
                                        <EndingPosition>494</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P32595.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10000472</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>G1 NPHE</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NPHE</LinearSequence>
                        <StartingPosition>499</StartingPosition>
                        <EndingPosition>502</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P32595.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10000472</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>45364</EpitopeId>
                <ReferenceStartingPosition>499</ReferenceStartingPosition>
                <ReferenceEndingPosition>502</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Authors cite previous reference (Cybinski et al., 1990, 1992) for the identification antigenic site G1 on BEFV G protein.  Antigenic sites were identified by competitive binding studies using Mabs and cross-reactivity of escape mutants.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figue 3</LocationOfData>
                        <BCellId>22799</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10000472</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Monoclonal antibodies specific to the G protein were raised by injection of mice with BEFV (BB7721).</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Overlapping octapeptides were synthesized based on Pepscan analysis of G1 antigenic site (aa487-503) and used in ELISA to determine binding of BEFV neutralizing mAbs.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>13A3, DB5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>aa496-503</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VNLNPHEK</LinearSequence>
                                        <StartingPosition>496</StartingPosition>
                                        <EndingPosition>503</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P32595.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10000472</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

